Skip to main content
G

GENETIC SIGNATURES LIMITED — Investor Relations & Filings

Ticker · GSS ISIN · AU000000GSS4 ASX Manufacturing
Open in API
Filings indexed 505 across all filing types
Latest filing 2026-04-21 Major Shareholding Noti…
Country AU Australia
Listing ASX GSS

About GENETIC SIGNATURES LIMITED

https://geneticsignatures.com

Genetic Signatures Limited is a molecular diagnostics company focused on the development and commercialization of platform technologies for the rapid detection of infectious diseases. The company utilizes its proprietary 3base™ technology, which simplifies the genomic sequence of pathogens by converting cytosine to thymine. This process reduces sequence complexity and increases the similarity between different strains of the same pathogen, enabling the design of highly multiplexed assays. Its primary product line, the EasyScreen™ Detection Kits, provides comprehensive screening solutions for various clinical applications, including respiratory infections, gastrointestinal diseases, and antimicrobial resistance. These kits are designed to integrate with automated laboratory workflows, offering high-throughput diagnostic capabilities to pathology laboratories and healthcare providers globally.

Recent filings

Filing Released Lang Actions
Change in substantial holding 4 pages 3.4MB
Major Shareholding Notification Classification · 1% confidence The document is an Australian Form 604 “Notice of change of interests of substantial holder” under the Corporations Act 2001, detailing changes in shareholding percentages and relevant interests. This falls squarely under notifications of significant share ownership changes (not director trades). Thus it is a Major Shareholding Notification (Code: MRQ).
2026-04-21 English
Change in substantial holding 4 pages 2.7MB
Major Shareholding Notification Classification · 1% confidence The document is an Australian Form 604 “Notice of change of interests of substantial holder” under the Corporations Act 2001, disclosing a substantial holder’s shareholding changes and voting power percentages. This is a notification of changes in significant share ownership levels (crossing thresholds), which corresponds exactly to our Major Shareholding Notification category (Code: MRQ).
2026-04-16 English
Change in substantial holding 4 pages 2.7MB
Major Shareholding Notification Classification · 1% confidence The document is a Form 604 Notice under the Australian Corporations Act (Section 671B) reporting a change in the interests of a substantial holder in Genetic Signatures Limited. This is a disclosure of a major shareholding notification (changes in relevant interests and voting power) rather than an annual report, earnings release, or board information. It therefore maps to Major Shareholding Notification (Code: MRQ).
2026-04-16 English
Genetic Signatures Signs Danish Supply Agreement 2 pages 269.1KB
Regulatory Filings Classification · 1% confidence The document is an ASX announcement detailing a commercial supply agreement for diagnostic equipment and reagents. It is not an annual or interim report, earnings release, proxy or governance statement, ESG report, capital raising or financing update, M&A or legal filing, nor a share issue or insider dealing notice. It simply announces a supply contract and does not fall under any of the highly specific categories, so it defaults to the general Regulatory Filings category (RNS).
2026-04-14 English
Pause in Trading 1 page 115.5KB
Regulatory Filings Classification · 1% confidence The document is a brief ASX Market Release announcing a temporary pause in trading of the company’s securities. It does not present financial results, AGM materials, or other specific report content but is a general regulatory announcement. This fits the Regulatory Filings (RNS) category as a fallback for miscellaneous compliance notices.
2026-04-14 English
Danish Supply Agreement - Additional Information 1
Regulatory Filings Classification · 1% confidence The document is an ASX announcement providing additional information on a commercial supply agreement, not an annual or interim report, dividend notice, capital change, share transaction, or management change. It does not present full financial results or formal filings like a 10-K/AR or IR, nor is it investor presentation or proxy. It serves as a general regulatory announcement of material information for investors. Therefore, it falls into the fallback category of Regulatory Filings (RNS).
2026-04-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.